PHAT – phathom pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Guggenheim Raises PT on Phathom Pharmaceuticals (PHAT) to $25 From $20, Here's Why [Yahoo! Finance]
Phathom Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Why Phathom Pharmaceuticals (PHAT) Is Up 13.2% After Guiding To 2026 Operating Profitability And Narrower Losses [Yahoo! Finance]
Phathom Pharmaceuticals (PHAT) had its price target raised by Guggenheim from $20.00 to $25.00. They now have a "buy" rating on the stock.
Phathom Pharmaceuticals (PHAT) was given a new $28.00 price target by Stifel Nicolaus.
Form 4 Phathom Pharmaceuticals, For: Feb 27 Filed by: Breedlove Robert Charles
Form 10-K Phathom Pharmaceuticals, For: Dec 31
Form 8-K Phathom Pharmaceuticals, For: Feb 26
Form 4 Phathom Pharmaceuticals, For: Feb 10 Filed by: Cook Anne Marie
Form 4 Phathom Pharmaceuticals, For: Feb 10 Filed by: Basta Steven L
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.